Skip to site navigation Skip to main content Skip to footer content Skip to Site Search page Skip to People Search page

Alerts and Updates

CMS Delays Data Collection Under ACA's Physician Payments Sunshine Act to January 1, 2013

May 9, 2012

CMS Delays Data Collection Under ACA's Physician Payments Sunshine Act to January 1, 2013

May 9, 2012

Read below

Even though CMS will not promulgate final rules until later this year, covered manufacturers and group may want to create internal procedures to collect the necessary data as soon as possible.

On May 3, 2012, the Centers for Medicare and Medicaid Services (CMS) officially announced that it will delay data-collection and reporting requirements under the Patient Protection and Affordable Care Act's (ACA) Physician Payments Sunshine Act (the "Sunshine Act"), due in part to the large number of comments received in response to CMS's December 19, 2011, proposed rules. Data collection by CMS will not start until at least January 1, 2013.

The Sunshine Act imposes two reporting requirements:

  1. Covered manufacturers must annually report payments or gifts to physicians or teaching hospitals; and
  2. Covered manufacturers and group purchasing organizations must annually report physician ownership and investment interests.

Although the Sunshine Act does not require report submissions until March 31, 2013, the first reporting period will cover payments made during fiscal year 2012. Thus, even though CMS will not promulgate final rules until later this year, covered manufacturers and group may want to create internal procedures to collect the necessary data as soon as possible.

For Further Information

If you have any questions about this Alert, please contact Frederick R. Ball, Elinor L. Hart, any member of the Pharmaceutical, Pharmacy & Food industry group or the attorney in the firm with whom you are regularly in contact.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.